lElevated temperature with radiographic pulmonary changes.
ALI was defined using the consensus definition of ALI: new onset hypoxemia or deterioration, demonstrated by a PaO2/FiO2 < 300 mmHg, with bilateral pulmonary changes, in the absence of cardiogenic pulmonary edema [ 30].
Suspected TRALI was scored using the consensus definition of ALI (new-onset hypoxemia or deterioration demonstrated by PaO2/FiO2 ratio < 300 mmHg within 6 hours after transfusion with bilateral pulmonary changes in the absence of cardiogenic pulmonary edema) [ 28- 30].
Patients with bilateral pulmonary changes on chest X-ray at admission to the ICU (n = 5) had a significant lower P/F ratio compared to patients without these changes (n = 54) (188 (60) vs 315 (105), P = 0.025), as expected.
A study from the Walter Reed Army Institute of Research showed low-level exposures to correlate with pathological pulmonary changes secondary to oxidative damage caused by antioxidant depletion – increasing the risk of long term problems such as respiratory insufficiency and adult respiratory distress syndrome.
By contrast, CDP7657 and other anti-CD40L antibody constructs lacking a functional Fc region, also administered at 50 mg/kg/week i.v., were associated with minimal pulmonary changes that were comparable in incidence and severity to those found in saline-treated control animals (Table 3; Fig. 5c and d).
Furthermore, a 24-week study in patients with type 1 diabetes and results from three phase III trials in patients with type 2 diabetes over a 2-year period provided further evidence that the antibody response did not correlate with pulmonary function changes or changes in glycemic control (Cefalu et al. 2005; Dumas et al. 2005b).
We confirmed earlier results, showing higher EBC 8-isoprostane concentrations, especially in patients with more advanced pulmonary changes.
In addition, in these patients levels of BALF sRAGE were elevated compared to patients with non-significant pulmonary changes on chest X-ray (97 (168) vs 18 (21) pg/mL, P <0.001).
COPDGene is another front line study that was first to define both genetic factors implicated in COPD, as well as to investigate structural pulmonary changes with CT.
